Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | YWHAG | P61981 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.40 |
| ▸ | PPARG | P37231 | 2/20 | 0.40 |
| ▸ | PPARA | Q07869 | 2/20 | 0.40 |
| ▸ | PAM | P19021 | 1/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.39 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.38 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.38 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.38 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.38 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.37 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14420220 | 0.91 | PPARA (0.47) | YWHAGALDH1A1PPARGPPARACYP4F2 | |
| SCHEMBL14420143 | 0.91 | ALDH1A1 (0.53) | YWHAGALDH1A1MAPK1L3MBTL1SLC7A5 | |
| SCHEMBL14420100 | 0.89 | SLC7A5 (0.43) | YWHAGALDH1A1MAPK1L3MBTL1SLC7A5 | |
| SCHEMBL2630609 | 0.87 | PPARA (0.51) | YWHAGALDH1A1MAPK1L3MBTL1SLC7A5 | |
| SCHEMBL14420094 | 0.87 | MAPK1 (0.43) | ALDH1A1MAPK1L3MBTL1SLC7A5PAM | |
| SCHEMBL14420123 | 0.82 | SLC7A5 (0.57) | ALDH1A1SLC7A5CYP4F2CYP4A11NLRP3 | |
| SCHEMBL14420169 | 0.82 | ALDH1A1 (0.50) | ALDH1A1MAPK1L3MBTL1PPARGPPARA | |
| SCHEMBL14420107 | 0.81 | PPARA (0.46) | YWHAGALDH1A1SLC7A5PPARGPPARA | |
| SCHEMBL18331645 | 0.80 | ALDH1A1 (0.63) | ALDH1A1MAPK1L3MBTL1PAMALOX5 | |
| SCHEMBL14420160 | 0.78 | ALDH1A1 (0.41) | ALDH1A1MAPK1L3MBTL1SLC7A5PAM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070225303-A1 | 8-Oxoadenine Compound | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2007-09-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070225303-A1 | 8-Oxoadenine Compound | TLR7, CCR8, TLR8 | YWHAG 3139/4885ALDH1A1 1017/4885MAPK1 2737/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.